HighVista Strategies’s Guardant Health GH Stock Holding History

HighVista Strategies’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.16M	Sell	23,357 -13,401	-36%	-$1.35M	0.6%	54
2025 Q4	$3.75M	Sell	36,758 -27,825	-43%	-$2.49M	0.97%	34
2025 Q3	$4.04M	Buy	64,583 +36,318	+128%	+$1.98M	0.99%	27
2025 Q2	$1.47M	Sell	28,265 -23,453	-45%	-$1.05M	0.54%	67
2025 Q1	$2.2M	Sell	51,718 -42,400	-45%	-$1.83M	0.85%	29
2024 Q4	$2.88M	Buy	+94,118	New	+$2.65M	1.07%	23

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighVista Strategies's GH Position: Q1 2026 in Review

HighVista Strategies reduced its Guardant Health (GH) stake by 36% in Q1 2026, selling an estimated $1.35M and leaving 23,357 shares worth $2.16M. The position accounts for 0.6% of the portfolio, ranked #54.

HighVista Strategies first reported a position in GH in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.04M in Q3 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

HighVista Strategies held 23,357 shares of Guardant Health worth $2.16M as of Q1 2026.
HighVista Strategies sold 13,401 Guardant Health shares in Q1 2026, an estimated $1.35M.
Guardant Health made up 0.6% of HighVista Strategies's portfolio in Q1 2026, its #54 holding.
HighVista Strategies first reported a position in Guardant Health in Q4 2024 and has held it in 6 quarters since.
HighVista Strategies's Guardant Health position peaked at $4.04M in Q3 2025.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on HighVista Strategies's 13F filing for Q1 2026, filed 15 May 2026.